Diet changes for chronic hives in teens
Part of Immune system & allergy, Skin clinical trials.
This study tests whether avoiding certain foods and food additives can reduce chronic hives (itchy welts on skin) in children and teenagers. Researchers will have participants follow a special diet and track their symptoms over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 1 to 18 years old
- Diagnosed with chronic spontaneous urticaria (ongoing hives not caused by a known trigger) lasting at least 6 weeks
- Active hives present when enrolling in the study
- You or your child can track symptoms and diet daily using forms or an app
- Willingness to follow the assigned diet plan for the study period
- Written permission from a parent or guardian (and child's agreement if old enough)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two diets — a Mediterranean diet and a low-histamine diet — to see if they help reduce hives in teenagers with chronic spontaneous urticaria. If your child qualifies, they will follow one of these diets for a period and we will monitor their symptoms.
This study looks at how diet and oxidative stress (a type of cell damage) affect the severity of chronic hives and how well patients respond to the medication omalizumab (Xolair). It may help find ways to improve treatment by understanding these factors.
This trial tests a new medication (HS-10561) first in healthy adults to check safety, then in people with chronic spontaneous urticaria (long-term hives without a known cause) to see if it helps reduce symptoms. It may be an option for those who have had hives for at least 6 months.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This trial tests a new medication called THB335 for people with chronic spontaneous urticaria (CSU), which causes hives and itching for months without a clear cause. The study will see if the drug can reduce hives and itching better than a placebo (a pill with no active medicine).
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
Hear when a new Pediatric Chronic Spontaneous Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.